CEO
Abrax Japan
The startup develops pharmaceutical drugs targeting autoimmune diseases by utilizing a unique mechanism that enhances skin health from within the body. This approach aims to improve treatment outcomes for patients suffering from skin-related autoimmune conditions.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$5.1MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops pharmaceutical drugs targeting autoimmune diseases by utilizing a unique mechanism that enhances skin health from within the body. This approach aims to improve treatment outcomes for patients suffering from skin-related autoimmune conditions.